nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—HTR6—Alzheimer's disease	0.192	0.427	CbGaD
Nortriptyline—PTGS1—Alzheimer's disease	0.0761	0.169	CbGaD
Nortriptyline—SLC6A4—Alzheimer's disease	0.0737	0.164	CbGaD
Nortriptyline—HTR2A—Donepezil—Alzheimer's disease	0.0735	0.243	CbGbCtD
Nortriptyline—DRD2—Memantine—Alzheimer's disease	0.0587	0.194	CbGbCtD
Nortriptyline—HTR2A—Alzheimer's disease	0.0566	0.126	CbGaD
Nortriptyline—CYP2D6—Alzheimer's disease	0.0518	0.115	CbGaD
Nortriptyline—CYP2D6—Rivastigmine—Alzheimer's disease	0.0306	0.101	CbGbCtD
Nortriptyline—CYP2C19—Memantine—Alzheimer's disease	0.0279	0.0921	CbGbCtD
Nortriptyline—CYP2C9—Donepezil—Alzheimer's disease	0.0267	0.0883	CbGbCtD
Nortriptyline—CYP2D6—Donepezil—Alzheimer's disease	0.0244	0.0808	CbGbCtD
Nortriptyline—CYP3A4—Rivastigmine—Alzheimer's disease	0.0194	0.0643	CbGbCtD
Nortriptyline—CYP2D6—Galantamine—Alzheimer's disease	0.0157	0.0521	CbGbCtD
Nortriptyline—CYP3A4—Donepezil—Alzheimer's disease	0.0155	0.0514	CbGbCtD
Nortriptyline—CYP3A4—Galantamine—Alzheimer's disease	0.01	0.0331	CbGbCtD
Nortriptyline—HTR2C—choroid plexus—Alzheimer's disease	0.00666	0.124	CbGeAlD
Nortriptyline—SLC6A2—locus ceruleus—Alzheimer's disease	0.00343	0.0638	CbGeAlD
Nortriptyline—HTR2A—choroid plexus—Alzheimer's disease	0.00334	0.0621	CbGeAlD
Nortriptyline—HTR2A—locus ceruleus—Alzheimer's disease	0.00206	0.0384	CbGeAlD
Nortriptyline—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00195	0.0363	CbGeAlD
Nortriptyline—HTR2A—cerebellar cortex—Alzheimer's disease	0.00168	0.0313	CbGeAlD
Nortriptyline—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00164	0.0305	CbGeAlD
Nortriptyline—DRD2—telencephalic ventricle—Alzheimer's disease	0.00148	0.0276	CbGeAlD
Nortriptyline—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000979	0.0182	CbGeAlD
Nortriptyline—HTR6—forebrain—Alzheimer's disease	0.000882	0.0164	CbGeAlD
Nortriptyline—HTR6—telencephalon—Alzheimer's disease	0.000811	0.0151	CbGeAlD
Nortriptyline—ADRA1D—forebrain—Alzheimer's disease	0.000688	0.0128	CbGeAlD
Nortriptyline—Olopatadine—S100B—Alzheimer's disease	0.000654	0.163	CrCbGaD
Nortriptyline—ADRA1D—telencephalon—Alzheimer's disease	0.000633	0.0118	CbGeAlD
Nortriptyline—PTGS1—blood vessel—Alzheimer's disease	0.000537	0.00998	CbGeAlD
Nortriptyline—CHRM4—nervous system—Alzheimer's disease	0.000535	0.00994	CbGeAlD
Nortriptyline—CHRM2—forebrain—Alzheimer's disease	0.000529	0.00982	CbGeAlD
Nortriptyline—CHRM4—central nervous system—Alzheimer's disease	0.000515	0.00957	CbGeAlD
Nortriptyline—HTR2C—forebrain—Alzheimer's disease	0.00051	0.00947	CbGeAlD
Nortriptyline—CHRM2—telencephalon—Alzheimer's disease	0.000486	0.00903	CbGeAlD
Nortriptyline—HTR2A—blood vessel—Alzheimer's disease	0.000484	0.009	CbGeAlD
Nortriptyline—SLC6A4—forebrain—Alzheimer's disease	0.000483	0.00898	CbGeAlD
Nortriptyline—CHRM1—forebrain—Alzheimer's disease	0.000481	0.00894	CbGeAlD
Nortriptyline—HTR6—nervous system—Alzheimer's disease	0.000479	0.00889	CbGeAlD
Nortriptyline—HTR2C—telencephalon—Alzheimer's disease	0.000469	0.00871	CbGeAlD
Nortriptyline—HTR6—central nervous system—Alzheimer's disease	0.000461	0.00856	CbGeAlD
Nortriptyline—SLC6A4—telencephalon—Alzheimer's disease	0.000444	0.00825	CbGeAlD
Nortriptyline—CHRM1—telencephalon—Alzheimer's disease	0.000442	0.00822	CbGeAlD
Nortriptyline—CHRM3—forebrain—Alzheimer's disease	0.000431	0.008	CbGeAlD
Nortriptyline—HTR1A—forebrain—Alzheimer's disease	0.000429	0.00797	CbGeAlD
Nortriptyline—SLC6A2—forebrain—Alzheimer's disease	0.000425	0.0079	CbGeAlD
Nortriptyline—CHRM5—nervous system—Alzheimer's disease	0.000418	0.00777	CbGeAlD
Nortriptyline—CHRM4—brain—Alzheimer's disease	0.000409	0.0076	CbGeAlD
Nortriptyline—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000404	0.0033	CcSEcCtD
Nortriptyline—CHRM5—central nervous system—Alzheimer's disease	0.000403	0.00748	CbGeAlD
Nortriptyline—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.000401	0.00327	CcSEcCtD
Nortriptyline—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.000399	0.00325	CcSEcCtD
Nortriptyline—CHRM3—telencephalon—Alzheimer's disease	0.000396	0.00736	CbGeAlD
Nortriptyline—ADRA1A—forebrain—Alzheimer's disease	0.000395	0.00735	CbGeAlD
Nortriptyline—Hepatitis—Galantamine—Alzheimer's disease	0.000395	0.00322	CcSEcCtD
Nortriptyline—HTR1A—telencephalon—Alzheimer's disease	0.000394	0.00733	CbGeAlD
Nortriptyline—Hallucination—Galantamine—Alzheimer's disease	0.000393	0.00321	CcSEcCtD
Nortriptyline—Psychotic disorder—Memantine—Alzheimer's disease	0.000393	0.0032	CcSEcCtD
Nortriptyline—SLC6A2—telencephalon—Alzheimer's disease	0.000391	0.00727	CbGeAlD
Nortriptyline—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00039	0.00318	CcSEcCtD
Nortriptyline—Oedema peripheral—Galantamine—Alzheimer's disease	0.000389	0.00318	CcSEcCtD
Nortriptyline—DRD2—forebrain—Alzheimer's disease	0.000388	0.0072	CbGeAlD
Nortriptyline—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000384	0.00313	CcSEcCtD
Nortriptyline—Irritability—Memantine—Alzheimer's disease	0.000384	0.00313	CcSEcCtD
Nortriptyline—Urinary retention—Memantine—Alzheimer's disease	0.000382	0.00312	CcSEcCtD
Nortriptyline—ADRA1B—nervous system—Alzheimer's disease	0.000382	0.0071	CbGeAlD
Nortriptyline—Eosinophilia—Donepezil—Alzheimer's disease	0.000379	0.00309	CcSEcCtD
Nortriptyline—Ataxia—Memantine—Alzheimer's disease	0.000378	0.00308	CcSEcCtD
Nortriptyline—Urinary retention—Rivastigmine—Alzheimer's disease	0.000374	0.00305	CcSEcCtD
Nortriptyline—ADRA1D—nervous system—Alzheimer's disease	0.000374	0.00694	CbGeAlD
Nortriptyline—Sweating increased—Donepezil—Alzheimer's disease	0.000373	0.00304	CcSEcCtD
Nortriptyline—Ataxia—Rivastigmine—Alzheimer's disease	0.00037	0.00302	CcSEcCtD
Nortriptyline—Eye disorder—Galantamine—Alzheimer's disease	0.000369	0.00301	CcSEcCtD
Nortriptyline—Tinnitus—Galantamine—Alzheimer's disease	0.000368	0.00301	CcSEcCtD
Nortriptyline—ADRA1B—central nervous system—Alzheimer's disease	0.000368	0.00683	CbGeAlD
Nortriptyline—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000367	0.003	CcSEcCtD
Nortriptyline—Flushing—Galantamine—Alzheimer's disease	0.000367	0.00299	CcSEcCtD
Nortriptyline—HTR6—brain—Alzheimer's disease	0.000366	0.0068	CbGeAlD
Nortriptyline—ADRA1A—telencephalon—Alzheimer's disease	0.000364	0.00675	CbGeAlD
Nortriptyline—ADRA1D—central nervous system—Alzheimer's disease	0.00036	0.00668	CbGeAlD
Nortriptyline—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000359	0.00293	CcSEcCtD
Nortriptyline—DRD2—telencephalon—Alzheimer's disease	0.000356	0.00662	CbGeAlD
Nortriptyline—Pollakiuria—Donepezil—Alzheimer's disease	0.000353	0.00288	CcSEcCtD
Nortriptyline—Arrhythmia—Galantamine—Alzheimer's disease	0.000353	0.00288	CcSEcCtD
Nortriptyline—Weight increased—Donepezil—Alzheimer's disease	0.000348	0.00284	CcSEcCtD
Nortriptyline—Weight decreased—Donepezil—Alzheimer's disease	0.000346	0.00282	CcSEcCtD
Nortriptyline—Sweating increased—Memantine—Alzheimer's disease	0.000338	0.00276	CcSEcCtD
Nortriptyline—Tension—Galantamine—Alzheimer's disease	0.000338	0.00275	CcSEcCtD
Nortriptyline—Dysgeusia—Galantamine—Alzheimer's disease	0.000337	0.00275	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000336	0.00274	CcSEcCtD
Nortriptyline—Myocardial infarction—Donepezil—Alzheimer's disease	0.000334	0.00273	CcSEcCtD
Nortriptyline—Nervousness—Galantamine—Alzheimer's disease	0.000334	0.00273	CcSEcCtD
Nortriptyline—Jaundice—Donepezil—Alzheimer's disease	0.000333	0.00271	CcSEcCtD
Nortriptyline—Sweating increased—Rivastigmine—Alzheimer's disease	0.000331	0.0027	CcSEcCtD
Nortriptyline—Pancytopenia—Memantine—Alzheimer's disease	0.00033	0.00269	CcSEcCtD
Nortriptyline—Sweating—Donepezil—Alzheimer's disease	0.000327	0.00267	CcSEcCtD
Nortriptyline—Vision blurred—Galantamine—Alzheimer's disease	0.000324	0.00265	CcSEcCtD
Nortriptyline—Tremor—Galantamine—Alzheimer's disease	0.000322	0.00263	CcSEcCtD
Nortriptyline—Pollakiuria—Memantine—Alzheimer's disease	0.000321	0.00262	CcSEcCtD
Nortriptyline—Erectile dysfunction—Memantine—Alzheimer's disease	0.00032	0.00261	CcSEcCtD
Nortriptyline—CHRM5—brain—Alzheimer's disease	0.00032	0.00594	CbGeAlD
Nortriptyline—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000319	0.0026	CcSEcCtD
Nortriptyline—Weight increased—Memantine—Alzheimer's disease	0.000316	0.00258	CcSEcCtD
Nortriptyline—Agitation—Galantamine—Alzheimer's disease	0.000316	0.00258	CcSEcCtD
Nortriptyline—Weight decreased—Memantine—Alzheimer's disease	0.000314	0.00256	CcSEcCtD
Nortriptyline—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000314	0.00256	CcSEcCtD
Nortriptyline—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000313	0.00255	CcSEcCtD
Nortriptyline—Malaise—Galantamine—Alzheimer's disease	0.00031	0.00253	CcSEcCtD
Nortriptyline—Weight increased—Rivastigmine—Alzheimer's disease	0.000309	0.00252	CcSEcCtD
Nortriptyline—Syncope—Galantamine—Alzheimer's disease	0.000308	0.00252	CcSEcCtD
Nortriptyline—ORM1—nervous system—Alzheimer's disease	0.000308	0.00572	CbGeAlD
Nortriptyline—Weight decreased—Rivastigmine—Alzheimer's disease	0.000307	0.00251	CcSEcCtD
Nortriptyline—Hepatitis—Donepezil—Alzheimer's disease	0.000306	0.0025	CcSEcCtD
Nortriptyline—HRH1—forebrain—Alzheimer's disease	0.000306	0.00569	CbGeAlD
Nortriptyline—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000305	0.00249	CcSEcCtD
Nortriptyline—Hallucination—Donepezil—Alzheimer's disease	0.000305	0.00249	CcSEcCtD
Nortriptyline—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000305	0.00249	CcSEcCtD
Nortriptyline—Palpitations—Galantamine—Alzheimer's disease	0.000304	0.00248	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000304	0.00248	CcSEcCtD
Nortriptyline—Myocardial infarction—Memantine—Alzheimer's disease	0.000304	0.00248	CcSEcCtD
Nortriptyline—Drowsiness—Rivastigmine—Alzheimer's disease	0.000303	0.00247	CcSEcCtD
Nortriptyline—Loss of consciousness—Galantamine—Alzheimer's disease	0.000302	0.00247	CcSEcCtD
Nortriptyline—Oedema peripheral—Donepezil—Alzheimer's disease	0.000302	0.00246	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000299	0.00244	CcSEcCtD
Nortriptyline—Convulsion—Galantamine—Alzheimer's disease	0.000298	0.00243	CcSEcCtD
Nortriptyline—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000297	0.00242	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000297	0.00242	CcSEcCtD
Nortriptyline—Hypertension—Galantamine—Alzheimer's disease	0.000297	0.00242	CcSEcCtD
Nortriptyline—ORM1—central nervous system—Alzheimer's disease	0.000296	0.00551	CbGeAlD
Nortriptyline—ADRA1B—brain—Alzheimer's disease	0.000292	0.00543	CbGeAlD
Nortriptyline—Anxiety—Galantamine—Alzheimer's disease	0.000292	0.00238	CcSEcCtD
Nortriptyline—Sweating—Rivastigmine—Alzheimer's disease	0.00029	0.00237	CcSEcCtD
Nortriptyline—Discomfort—Galantamine—Alzheimer's disease	0.000289	0.00236	CcSEcCtD
Nortriptyline—Agranulocytosis—Memantine—Alzheimer's disease	0.000289	0.00236	CcSEcCtD
Nortriptyline—HTR2A—embryo—Alzheimer's disease	0.000289	0.00537	CbGeAlD
Nortriptyline—CHRM2—nervous system—Alzheimer's disease	0.000287	0.00533	CbGeAlD
Nortriptyline—Dry mouth—Galantamine—Alzheimer's disease	0.000286	0.00234	CcSEcCtD
Nortriptyline—ADRA1D—brain—Alzheimer's disease	0.000286	0.00531	CbGeAlD
Nortriptyline—Tinnitus—Donepezil—Alzheimer's disease	0.000286	0.00233	CcSEcCtD
Nortriptyline—PTGS1—forebrain—Alzheimer's disease	0.000283	0.00526	CbGeAlD
Nortriptyline—Confusional state—Galantamine—Alzheimer's disease	0.000283	0.00231	CcSEcCtD
Nortriptyline—HRH1—telencephalon—Alzheimer's disease	0.000281	0.00523	CbGeAlD
Nortriptyline—Hepatitis—Memantine—Alzheimer's disease	0.000278	0.00227	CcSEcCtD
Nortriptyline—Hallucination—Memantine—Alzheimer's disease	0.000277	0.00226	CcSEcCtD
Nortriptyline—Hypoaesthesia—Memantine—Alzheimer's disease	0.000277	0.00226	CcSEcCtD
Nortriptyline—HTR2C—nervous system—Alzheimer's disease	0.000277	0.00514	CbGeAlD
Nortriptyline—CHRM2—central nervous system—Alzheimer's disease	0.000276	0.00513	CbGeAlD
Nortriptyline—Shock—Galantamine—Alzheimer's disease	0.000276	0.00225	CcSEcCtD
Nortriptyline—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000275	0.00224	CcSEcCtD
Nortriptyline—Tachycardia—Galantamine—Alzheimer's disease	0.000274	0.00224	CcSEcCtD
Nortriptyline—Oedema peripheral—Memantine—Alzheimer's disease	0.000274	0.00224	CcSEcCtD
Nortriptyline—Arrhythmia—Donepezil—Alzheimer's disease	0.000274	0.00223	CcSEcCtD
Nortriptyline—Hepatitis—Rivastigmine—Alzheimer's disease	0.000272	0.00222	CcSEcCtD
Nortriptyline—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000271	0.00221	CcSEcCtD
Nortriptyline—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000271	0.00221	CcSEcCtD
Nortriptyline—Hallucination—Rivastigmine—Alzheimer's disease	0.000271	0.00221	CcSEcCtD
Nortriptyline—Alopecia—Donepezil—Alzheimer's disease	0.000271	0.00221	CcSEcCtD
Nortriptyline—CYP2E1—telencephalon—Alzheimer's disease	0.00027	0.00502	CbGeAlD
Nortriptyline—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000268	0.00219	CcSEcCtD
Nortriptyline—Anorexia—Galantamine—Alzheimer's disease	0.000268	0.00218	CcSEcCtD
Nortriptyline—HTR2C—central nervous system—Alzheimer's disease	0.000266	0.00495	CbGeAlD
Nortriptyline—Hypotension—Galantamine—Alzheimer's disease	0.000262	0.00214	CcSEcCtD
Nortriptyline—SLC6A4—nervous system—Alzheimer's disease	0.000262	0.00487	CbGeAlD
Nortriptyline—Tension—Donepezil—Alzheimer's disease	0.000262	0.00213	CcSEcCtD
Nortriptyline—CHRM1—nervous system—Alzheimer's disease	0.000261	0.00485	CbGeAlD
Nortriptyline—Dysgeusia—Donepezil—Alzheimer's disease	0.000261	0.00213	CcSEcCtD
Nortriptyline—PTGS1—telencephalon—Alzheimer's disease	0.00026	0.00484	CbGeAlD
Nortriptyline—Eye disorder—Memantine—Alzheimer's disease	0.00026	0.00212	CcSEcCtD
Nortriptyline—Tinnitus—Memantine—Alzheimer's disease	0.000259	0.00212	CcSEcCtD
Nortriptyline—Nervousness—Donepezil—Alzheimer's disease	0.000259	0.00211	CcSEcCtD
Nortriptyline—Flushing—Memantine—Alzheimer's disease	0.000258	0.00211	CcSEcCtD
Nortriptyline—HTR2A—forebrain—Alzheimer's disease	0.000256	0.00475	CbGeAlD
Nortriptyline—Eye disorder—Rivastigmine—Alzheimer's disease	0.000254	0.00207	CcSEcCtD
Nortriptyline—Insomnia—Galantamine—Alzheimer's disease	0.000254	0.00207	CcSEcCtD
Nortriptyline—Tinnitus—Rivastigmine—Alzheimer's disease	0.000254	0.00207	CcSEcCtD
Nortriptyline—Flushing—Rivastigmine—Alzheimer's disease	0.000252	0.00206	CcSEcCtD
Nortriptyline—SLC6A4—central nervous system—Alzheimer's disease	0.000252	0.00469	CbGeAlD
Nortriptyline—Paraesthesia—Galantamine—Alzheimer's disease	0.000252	0.00206	CcSEcCtD
Nortriptyline—CHRM1—central nervous system—Alzheimer's disease	0.000251	0.00467	CbGeAlD
Nortriptyline—Vision blurred—Donepezil—Alzheimer's disease	0.000251	0.00205	CcSEcCtD
Nortriptyline—Tremor—Donepezil—Alzheimer's disease	0.00025	0.00204	CcSEcCtD
Nortriptyline—Somnolence—Galantamine—Alzheimer's disease	0.00025	0.00204	CcSEcCtD
Nortriptyline—Arrhythmia—Memantine—Alzheimer's disease	0.000248	0.00203	CcSEcCtD
Nortriptyline—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000247	0.00202	CcSEcCtD
Nortriptyline—Dyspepsia—Galantamine—Alzheimer's disease	0.000247	0.00202	CcSEcCtD
Nortriptyline—Alopecia—Memantine—Alzheimer's disease	0.000246	0.00201	CcSEcCtD
Nortriptyline—Agitation—Donepezil—Alzheimer's disease	0.000245	0.002	CcSEcCtD
Nortriptyline—Decreased appetite—Galantamine—Alzheimer's disease	0.000244	0.00199	CcSEcCtD
Nortriptyline—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000243	0.00198	CcSEcCtD
Nortriptyline—Fatigue—Galantamine—Alzheimer's disease	0.000242	0.00198	CcSEcCtD
Nortriptyline—Malaise—Donepezil—Alzheimer's disease	0.00024	0.00196	CcSEcCtD
Nortriptyline—Alopecia—Rivastigmine—Alzheimer's disease	0.00024	0.00196	CcSEcCtD
Nortriptyline—Constipation—Galantamine—Alzheimer's disease	0.00024	0.00196	CcSEcCtD
Nortriptyline—Syncope—Donepezil—Alzheimer's disease	0.000239	0.00195	CcSEcCtD
Nortriptyline—Tension—Memantine—Alzheimer's disease	0.000238	0.00194	CcSEcCtD
Nortriptyline—Dysgeusia—Memantine—Alzheimer's disease	0.000237	0.00193	CcSEcCtD
Nortriptyline—Nervousness—Memantine—Alzheimer's disease	0.000235	0.00192	CcSEcCtD
Nortriptyline—HTR2A—telencephalon—Alzheimer's disease	0.000235	0.00437	CbGeAlD
Nortriptyline—Loss of consciousness—Donepezil—Alzheimer's disease	0.000234	0.00191	CcSEcCtD
Nortriptyline—Amitriptyline—NTRK2—Alzheimer's disease	0.000234	0.0583	CrCbGaD
Nortriptyline—CHRM3—nervous system—Alzheimer's disease	0.000234	0.00434	CbGeAlD
Nortriptyline—CYP2D6—forebrain—Alzheimer's disease	0.000233	0.00433	CbGeAlD
Nortriptyline—HTR1A—nervous system—Alzheimer's disease	0.000233	0.00433	CbGeAlD
Nortriptyline—Tension—Rivastigmine—Alzheimer's disease	0.000232	0.0019	CcSEcCtD
Nortriptyline—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000232	0.00189	CcSEcCtD
Nortriptyline—Feeling abnormal—Galantamine—Alzheimer's disease	0.000231	0.00189	CcSEcCtD
Nortriptyline—Convulsion—Donepezil—Alzheimer's disease	0.000231	0.00189	CcSEcCtD
Nortriptyline—SLC6A2—nervous system—Alzheimer's disease	0.000231	0.00429	CbGeAlD
Nortriptyline—Hypertension—Donepezil—Alzheimer's disease	0.00023	0.00188	CcSEcCtD
Nortriptyline—Nervousness—Rivastigmine—Alzheimer's disease	0.00023	0.00188	CcSEcCtD
Nortriptyline—Vision blurred—Memantine—Alzheimer's disease	0.000228	0.00186	CcSEcCtD
Nortriptyline—Tremor—Memantine—Alzheimer's disease	0.000227	0.00185	CcSEcCtD
Nortriptyline—Anxiety—Donepezil—Alzheimer's disease	0.000226	0.00185	CcSEcCtD
Nortriptyline—CHRM3—central nervous system—Alzheimer's disease	0.000225	0.00418	CbGeAlD
Nortriptyline—Ill-defined disorder—Memantine—Alzheimer's disease	0.000225	0.00183	CcSEcCtD
Nortriptyline—Discomfort—Donepezil—Alzheimer's disease	0.000224	0.00183	CcSEcCtD
Nortriptyline—Cyproheptadine—HTR6—Alzheimer's disease	0.000224	0.0559	CrCbGaD
Nortriptyline—HTR1A—central nervous system—Alzheimer's disease	0.000224	0.00417	CbGeAlD
Nortriptyline—Vision blurred—Rivastigmine—Alzheimer's disease	0.000223	0.00182	CcSEcCtD
Nortriptyline—Agitation—Memantine—Alzheimer's disease	0.000222	0.00182	CcSEcCtD
Nortriptyline—SLC6A2—central nervous system—Alzheimer's disease	0.000222	0.00413	CbGeAlD
Nortriptyline—Dry mouth—Donepezil—Alzheimer's disease	0.000222	0.00181	CcSEcCtD
Nortriptyline—Body temperature increased—Galantamine—Alzheimer's disease	0.000222	0.00181	CcSEcCtD
Nortriptyline—Abdominal pain—Galantamine—Alzheimer's disease	0.000222	0.00181	CcSEcCtD
Nortriptyline—Tremor—Rivastigmine—Alzheimer's disease	0.000222	0.00181	CcSEcCtD
Nortriptyline—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00022	0.00179	CcSEcCtD
Nortriptyline—Confusional state—Donepezil—Alzheimer's disease	0.000219	0.00179	CcSEcCtD
Nortriptyline—CHRM2—brain—Alzheimer's disease	0.000219	0.00408	CbGeAlD
Nortriptyline—HTR1A—cerebellum—Alzheimer's disease	0.000219	0.00407	CbGeAlD
Nortriptyline—Malaise—Memantine—Alzheimer's disease	0.000218	0.00178	CcSEcCtD
Nortriptyline—Agitation—Rivastigmine—Alzheimer's disease	0.000218	0.00178	CcSEcCtD
Nortriptyline—Oedema—Donepezil—Alzheimer's disease	0.000218	0.00178	CcSEcCtD
Nortriptyline—Syncope—Memantine—Alzheimer's disease	0.000217	0.00177	CcSEcCtD
Nortriptyline—Leukopenia—Memantine—Alzheimer's disease	0.000217	0.00177	CcSEcCtD
Nortriptyline—ADRA1A—nervous system—Alzheimer's disease	0.000215	0.00399	CbGeAlD
Nortriptyline—CYP2D6—telencephalon—Alzheimer's disease	0.000214	0.00398	CbGeAlD
Nortriptyline—Shock—Donepezil—Alzheimer's disease	0.000214	0.00175	CcSEcCtD
Nortriptyline—Palpitations—Memantine—Alzheimer's disease	0.000214	0.00175	CcSEcCtD
Nortriptyline—Malaise—Rivastigmine—Alzheimer's disease	0.000214	0.00174	CcSEcCtD
Nortriptyline—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000213	0.00174	CcSEcCtD
Nortriptyline—Loss of consciousness—Memantine—Alzheimer's disease	0.000213	0.00174	CcSEcCtD
Nortriptyline—Syncope—Rivastigmine—Alzheimer's disease	0.000212	0.00173	CcSEcCtD
Nortriptyline—HTR2C—brain—Alzheimer's disease	0.000211	0.00393	CbGeAlD
Nortriptyline—DRD2—nervous system—Alzheimer's disease	0.00021	0.00391	CbGeAlD
Nortriptyline—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00021	0.00172	CcSEcCtD
Nortriptyline—Convulsion—Memantine—Alzheimer's disease	0.00021	0.00171	CcSEcCtD
Nortriptyline—Palpitations—Rivastigmine—Alzheimer's disease	0.000209	0.00171	CcSEcCtD
Nortriptyline—Hypertension—Memantine—Alzheimer's disease	0.000209	0.00171	CcSEcCtD
Nortriptyline—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000208	0.0017	CcSEcCtD
Nortriptyline—Anorexia—Donepezil—Alzheimer's disease	0.000207	0.00169	CcSEcCtD
Nortriptyline—Hypersensitivity—Galantamine—Alzheimer's disease	0.000207	0.00169	CcSEcCtD
Nortriptyline—ADRA1A—central nervous system—Alzheimer's disease	0.000207	0.00384	CbGeAlD
Nortriptyline—ALB—brain—Alzheimer's disease	0.000206	0.00383	CbGeAlD
Nortriptyline—Anxiety—Memantine—Alzheimer's disease	0.000205	0.00168	CcSEcCtD
Nortriptyline—Convulsion—Rivastigmine—Alzheimer's disease	0.000205	0.00167	CcSEcCtD
Nortriptyline—Hypertension—Rivastigmine—Alzheimer's disease	0.000204	0.00167	CcSEcCtD
Nortriptyline—Discomfort—Memantine—Alzheimer's disease	0.000204	0.00166	CcSEcCtD
Nortriptyline—Hypotension—Donepezil—Alzheimer's disease	0.000203	0.00166	CcSEcCtD
Nortriptyline—DRD2—central nervous system—Alzheimer's disease	0.000203	0.00376	CbGeAlD
Nortriptyline—ADRA1A—cerebellum—Alzheimer's disease	0.000202	0.00375	CbGeAlD
Nortriptyline—Dry mouth—Memantine—Alzheimer's disease	0.000202	0.00164	CcSEcCtD
Nortriptyline—Asthenia—Galantamine—Alzheimer's disease	0.000201	0.00164	CcSEcCtD
Nortriptyline—Anxiety—Rivastigmine—Alzheimer's disease	0.000201	0.00164	CcSEcCtD
Nortriptyline—SLC6A4—brain—Alzheimer's disease	0.0002	0.00372	CbGeAlD
Nortriptyline—CHRM1—brain—Alzheimer's disease	0.0002	0.00371	CbGeAlD
Nortriptyline—Confusional state—Memantine—Alzheimer's disease	0.000199	0.00163	CcSEcCtD
Nortriptyline—Discomfort—Rivastigmine—Alzheimer's disease	0.000199	0.00163	CcSEcCtD
Nortriptyline—DRD2—cerebellum—Alzheimer's disease	0.000198	0.00368	CbGeAlD
Nortriptyline—Oedema—Memantine—Alzheimer's disease	0.000198	0.00161	CcSEcCtD
Nortriptyline—Dry mouth—Rivastigmine—Alzheimer's disease	0.000197	0.00161	CcSEcCtD
Nortriptyline—Insomnia—Donepezil—Alzheimer's disease	0.000197	0.00161	CcSEcCtD
Nortriptyline—Paraesthesia—Donepezil—Alzheimer's disease	0.000195	0.00159	CcSEcCtD
Nortriptyline—Confusional state—Rivastigmine—Alzheimer's disease	0.000195	0.00159	CcSEcCtD
Nortriptyline—Shock—Memantine—Alzheimer's disease	0.000194	0.00159	CcSEcCtD
Nortriptyline—Somnolence—Donepezil—Alzheimer's disease	0.000193	0.00158	CcSEcCtD
Nortriptyline—Thrombocytopenia—Memantine—Alzheimer's disease	0.000193	0.00158	CcSEcCtD
Nortriptyline—Oedema—Rivastigmine—Alzheimer's disease	0.000193	0.00158	CcSEcCtD
Nortriptyline—Tachycardia—Memantine—Alzheimer's disease	0.000193	0.00157	CcSEcCtD
Nortriptyline—Diarrhoea—Galantamine—Alzheimer's disease	0.000192	0.00157	CcSEcCtD
Nortriptyline—Dyspepsia—Donepezil—Alzheimer's disease	0.000192	0.00156	CcSEcCtD
Nortriptyline—Hyperhidrosis—Memantine—Alzheimer's disease	0.000191	0.00156	CcSEcCtD
Nortriptyline—Shock—Rivastigmine—Alzheimer's disease	0.00019	0.00155	CcSEcCtD
Nortriptyline—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000189	0.00154	CcSEcCtD
Nortriptyline—Decreased appetite—Donepezil—Alzheimer's disease	0.000189	0.00154	CcSEcCtD
Nortriptyline—Tachycardia—Rivastigmine—Alzheimer's disease	0.000189	0.00154	CcSEcCtD
Nortriptyline—Anorexia—Memantine—Alzheimer's disease	0.000188	0.00154	CcSEcCtD
Nortriptyline—Fatigue—Donepezil—Alzheimer's disease	0.000188	0.00153	CcSEcCtD
Nortriptyline—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000187	0.00152	CcSEcCtD
Nortriptyline—Constipation—Donepezil—Alzheimer's disease	0.000186	0.00152	CcSEcCtD
Nortriptyline—Dizziness—Galantamine—Alzheimer's disease	0.000186	0.00152	CcSEcCtD
Nortriptyline—Hypotension—Memantine—Alzheimer's disease	0.000185	0.00151	CcSEcCtD
Nortriptyline—Anorexia—Rivastigmine—Alzheimer's disease	0.000184	0.0015	CcSEcCtD
Nortriptyline—Hypotension—Rivastigmine—Alzheimer's disease	0.000181	0.00147	CcSEcCtD
Nortriptyline—Feeling abnormal—Donepezil—Alzheimer's disease	0.000179	0.00146	CcSEcCtD
Nortriptyline—Insomnia—Memantine—Alzheimer's disease	0.000179	0.00146	CcSEcCtD
Nortriptyline—CHRM3—brain—Alzheimer's disease	0.000179	0.00332	CbGeAlD
Nortriptyline—Vomiting—Galantamine—Alzheimer's disease	0.000178	0.00146	CcSEcCtD
Nortriptyline—HTR1A—brain—Alzheimer's disease	0.000178	0.00331	CbGeAlD
Nortriptyline—Paraesthesia—Memantine—Alzheimer's disease	0.000177	0.00145	CcSEcCtD
Nortriptyline—Rash—Galantamine—Alzheimer's disease	0.000177	0.00144	CcSEcCtD
Nortriptyline—Dermatitis—Galantamine—Alzheimer's disease	0.000177	0.00144	CcSEcCtD
Nortriptyline—SLC6A2—brain—Alzheimer's disease	0.000176	0.00328	CbGeAlD
Nortriptyline—Headache—Galantamine—Alzheimer's disease	0.000176	0.00144	CcSEcCtD
Nortriptyline—Somnolence—Memantine—Alzheimer's disease	0.000176	0.00143	CcSEcCtD
Nortriptyline—Insomnia—Rivastigmine—Alzheimer's disease	0.000175	0.00143	CcSEcCtD
Nortriptyline—Dyspepsia—Memantine—Alzheimer's disease	0.000174	0.00142	CcSEcCtD
Nortriptyline—Atomoxetine—HTR6—Alzheimer's disease	0.000174	0.0433	CrCbGaD
Nortriptyline—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000174	0.00142	CcSEcCtD
Nortriptyline—Urticaria—Donepezil—Alzheimer's disease	0.000173	0.00141	CcSEcCtD
Nortriptyline—Body temperature increased—Donepezil—Alzheimer's disease	0.000172	0.0014	CcSEcCtD
Nortriptyline—Abdominal pain—Donepezil—Alzheimer's disease	0.000172	0.0014	CcSEcCtD
Nortriptyline—Somnolence—Rivastigmine—Alzheimer's disease	0.000172	0.0014	CcSEcCtD
Nortriptyline—Decreased appetite—Memantine—Alzheimer's disease	0.000172	0.0014	CcSEcCtD
Nortriptyline—Fatigue—Memantine—Alzheimer's disease	0.00017	0.00139	CcSEcCtD
Nortriptyline—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00017	0.00139	CcSEcCtD
Nortriptyline—Mianserin—HTR6—Alzheimer's disease	0.00017	0.0423	CrCbGaD
Nortriptyline—Constipation—Memantine—Alzheimer's disease	0.000169	0.00138	CcSEcCtD
Nortriptyline—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000168	0.00137	CcSEcCtD
Nortriptyline—Nausea—Galantamine—Alzheimer's disease	0.000167	0.00136	CcSEcCtD
Nortriptyline—Fatigue—Rivastigmine—Alzheimer's disease	0.000167	0.00136	CcSEcCtD
Nortriptyline—HRH1—nervous system—Alzheimer's disease	0.000166	0.00309	CbGeAlD
Nortriptyline—Constipation—Rivastigmine—Alzheimer's disease	0.000165	0.00135	CcSEcCtD
Nortriptyline—ADRA1A—brain—Alzheimer's disease	0.000164	0.00305	CbGeAlD
Nortriptyline—Feeling abnormal—Memantine—Alzheimer's disease	0.000163	0.00133	CcSEcCtD
Nortriptyline—DRD2—brain—Alzheimer's disease	0.000161	0.00299	CbGeAlD
Nortriptyline—Hypersensitivity—Donepezil—Alzheimer's disease	0.00016	0.00131	CcSEcCtD
Nortriptyline—HRH1—central nervous system—Alzheimer's disease	0.00016	0.00297	CbGeAlD
Nortriptyline—CYP2E1—nervous system—Alzheimer's disease	0.00016	0.00297	CbGeAlD
Nortriptyline—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000159	0.0013	CcSEcCtD
Nortriptyline—Urticaria—Memantine—Alzheimer's disease	0.000157	0.00128	CcSEcCtD
Nortriptyline—Body temperature increased—Memantine—Alzheimer's disease	0.000156	0.00127	CcSEcCtD
Nortriptyline—Abdominal pain—Memantine—Alzheimer's disease	0.000156	0.00127	CcSEcCtD
Nortriptyline—Asthenia—Donepezil—Alzheimer's disease	0.000156	0.00127	CcSEcCtD
Nortriptyline—Clomipramine—HTR6—Alzheimer's disease	0.000155	0.0387	CrCbGaD
Nortriptyline—Chlorprothixene—HTR6—Alzheimer's disease	0.000155	0.0386	CrCbGaD
Nortriptyline—Pruritus—Donepezil—Alzheimer's disease	0.000154	0.00126	CcSEcCtD
Nortriptyline—PTGS1—nervous system—Alzheimer's disease	0.000154	0.00286	CbGeAlD
Nortriptyline—CYP2E1—central nervous system—Alzheimer's disease	0.000154	0.00286	CbGeAlD
Nortriptyline—Urticaria—Rivastigmine—Alzheimer's disease	0.000154	0.00125	CcSEcCtD
Nortriptyline—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000153	0.00125	CcSEcCtD
Nortriptyline—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000153	0.00125	CcSEcCtD
Nortriptyline—Protriptyline—SLC6A4—Alzheimer's disease	0.000152	0.0378	CrCbGaD
Nortriptyline—CYP2E1—cerebellum—Alzheimer's disease	0.00015	0.00279	CbGeAlD
Nortriptyline—Diarrhoea—Donepezil—Alzheimer's disease	0.000149	0.00121	CcSEcCtD
Nortriptyline—PTGS1—central nervous system—Alzheimer's disease	0.000148	0.00275	CbGeAlD
Nortriptyline—Hypersensitivity—Memantine—Alzheimer's disease	0.000146	0.00119	CcSEcCtD
Nortriptyline—Dizziness—Donepezil—Alzheimer's disease	0.000144	0.00117	CcSEcCtD
Nortriptyline—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000142	0.00116	CcSEcCtD
Nortriptyline—Asthenia—Memantine—Alzheimer's disease	0.000142	0.00116	CcSEcCtD
Nortriptyline—Pruritus—Memantine—Alzheimer's disease	0.00014	0.00114	CcSEcCtD
Nortriptyline—HTR2A—nervous system—Alzheimer's disease	0.000139	0.00258	CbGeAlD
Nortriptyline—Asthenia—Rivastigmine—Alzheimer's disease	0.000139	0.00113	CcSEcCtD
Nortriptyline—Vomiting—Donepezil—Alzheimer's disease	0.000138	0.00113	CcSEcCtD
Nortriptyline—Rash—Donepezil—Alzheimer's disease	0.000137	0.00112	CcSEcCtD
Nortriptyline—Dermatitis—Donepezil—Alzheimer's disease	0.000137	0.00112	CcSEcCtD
Nortriptyline—Pruritus—Rivastigmine—Alzheimer's disease	0.000137	0.00112	CcSEcCtD
Nortriptyline—Headache—Donepezil—Alzheimer's disease	0.000136	0.00111	CcSEcCtD
Nortriptyline—Doxepin—HTR6—Alzheimer's disease	0.000136	0.034	CrCbGaD
Nortriptyline—Diarrhoea—Memantine—Alzheimer's disease	0.000135	0.0011	CcSEcCtD
Nortriptyline—HTR2A—central nervous system—Alzheimer's disease	0.000134	0.00248	CbGeAlD
Nortriptyline—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000132	0.00108	CcSEcCtD
Nortriptyline—Dizziness—Memantine—Alzheimer's disease	0.000131	0.00107	CcSEcCtD
Nortriptyline—HTR2A—cerebellum—Alzheimer's disease	0.000131	0.00243	CbGeAlD
Nortriptyline—Nausea—Donepezil—Alzheimer's disease	0.000129	0.00105	CcSEcCtD
Nortriptyline—CYP3A4—nervous system—Alzheimer's disease	0.000128	0.00239	CbGeAlD
Nortriptyline—Dizziness—Rivastigmine—Alzheimer's disease	0.000128	0.00104	CcSEcCtD
Nortriptyline—HRH1—brain—Alzheimer's disease	0.000127	0.00236	CbGeAlD
Nortriptyline—CYP2D6—nervous system—Alzheimer's disease	0.000126	0.00235	CbGeAlD
Nortriptyline—Vomiting—Memantine—Alzheimer's disease	0.000126	0.00103	CcSEcCtD
Nortriptyline—Rash—Memantine—Alzheimer's disease	0.000125	0.00102	CcSEcCtD
Nortriptyline—Dermatitis—Memantine—Alzheimer's disease	0.000124	0.00102	CcSEcCtD
Nortriptyline—Headache—Memantine—Alzheimer's disease	0.000124	0.00101	CcSEcCtD
Nortriptyline—CYP3A4—central nervous system—Alzheimer's disease	0.000124	0.0023	CbGeAlD
Nortriptyline—Vomiting—Rivastigmine—Alzheimer's disease	0.000123	0.001	CcSEcCtD
Nortriptyline—CYP2E1—brain—Alzheimer's disease	0.000122	0.00227	CbGeAlD
Nortriptyline—Rash—Rivastigmine—Alzheimer's disease	0.000122	0.000994	CcSEcCtD
Nortriptyline—Dermatitis—Rivastigmine—Alzheimer's disease	0.000122	0.000994	CcSEcCtD
Nortriptyline—CYP2D6—central nervous system—Alzheimer's disease	0.000122	0.00226	CbGeAlD
Nortriptyline—Headache—Rivastigmine—Alzheimer's disease	0.000121	0.000988	CcSEcCtD
Nortriptyline—CYP2D6—cerebellum—Alzheimer's disease	0.000119	0.00221	CbGeAlD
Nortriptyline—PTGS1—brain—Alzheimer's disease	0.000118	0.00218	CbGeAlD
Nortriptyline—Nausea—Memantine—Alzheimer's disease	0.000117	0.000958	CcSEcCtD
Nortriptyline—Nausea—Rivastigmine—Alzheimer's disease	0.000115	0.000937	CcSEcCtD
Nortriptyline—Protriptyline—CYP2D6—Alzheimer's disease	0.000107	0.0266	CrCbGaD
Nortriptyline—HTR2A—brain—Alzheimer's disease	0.000106	0.00197	CbGeAlD
Nortriptyline—Imipramine—HTR6—Alzheimer's disease	0.000106	0.0264	CrCbGaD
Nortriptyline—Amitriptyline—HTR6—Alzheimer's disease	0.000105	0.0263	CrCbGaD
Nortriptyline—CYP2D6—brain—Alzheimer's disease	9.66e-05	0.0018	CbGeAlD
Nortriptyline—Cyclobenzaprine—HTR2A—Alzheimer's disease	8.7e-05	0.0217	CrCbGaD
Nortriptyline—Epinastine—HTR2A—Alzheimer's disease	8.64e-05	0.0215	CrCbGaD
Nortriptyline—Cyclobenzaprine—CYP2D6—Alzheimer's disease	7.96e-05	0.0198	CrCbGaD
Nortriptyline—Epinastine—CYP2D6—Alzheimer's disease	7.9e-05	0.0197	CrCbGaD
Nortriptyline—Maprotiline—HTR2A—Alzheimer's disease	7.44e-05	0.0185	CrCbGaD
Nortriptyline—Maprotiline—CYP2D6—Alzheimer's disease	6.8e-05	0.0169	CrCbGaD
Nortriptyline—Atomoxetine—SLC6A4—Alzheimer's disease	6.66e-05	0.0166	CrCbGaD
Nortriptyline—Cyproheptadine—HTR2A—Alzheimer's disease	6.6e-05	0.0164	CrCbGaD
Nortriptyline—Mianserin—SLC6A4—Alzheimer's disease	6.5e-05	0.0162	CrCbGaD
Nortriptyline—Clomipramine—SLC6A4—Alzheimer's disease	5.95e-05	0.0148	CrCbGaD
Nortriptyline—Trimipramine—SLC6A4—Alzheimer's disease	5.47e-05	0.0136	CrCbGaD
Nortriptyline—Doxepin—SLC6A4—Alzheimer's disease	5.22e-05	0.013	CrCbGaD
Nortriptyline—Atomoxetine—HTR2A—Alzheimer's disease	5.11e-05	0.0127	CrCbGaD
Nortriptyline—Mianserin—HTR2A—Alzheimer's disease	5e-05	0.0125	CrCbGaD
Nortriptyline—Desipramine—SLC6A4—Alzheimer's disease	4.79e-05	0.0119	CrCbGaD
Nortriptyline—Atomoxetine—CYP2D6—Alzheimer's disease	4.68e-05	0.0117	CrCbGaD
Nortriptyline—Clomipramine—HTR2A—Alzheimer's disease	4.57e-05	0.0114	CrCbGaD
Nortriptyline—Mianserin—CYP2D6—Alzheimer's disease	4.57e-05	0.0114	CrCbGaD
Nortriptyline—Chlorprothixene—HTR2A—Alzheimer's disease	4.55e-05	0.0113	CrCbGaD
Nortriptyline—Trimipramine—HTR2A—Alzheimer's disease	4.21e-05	0.0105	CrCbGaD
Nortriptyline—Clomipramine—CYP2D6—Alzheimer's disease	4.18e-05	0.0104	CrCbGaD
Nortriptyline—Imipramine—SLC6A4—Alzheimer's disease	4.06e-05	0.0101	CrCbGaD
Nortriptyline—Amitriptyline—SLC6A4—Alzheimer's disease	4.03e-05	0.0101	CrCbGaD
Nortriptyline—Doxepin—HTR2A—Alzheimer's disease	4.01e-05	0.00999	CrCbGaD
Nortriptyline—Trimipramine—CYP2D6—Alzheimer's disease	3.85e-05	0.00959	CrCbGaD
Nortriptyline—Desipramine—HTR2A—Alzheimer's disease	3.68e-05	0.00917	CrCbGaD
Nortriptyline—Doxepin—CYP2D6—Alzheimer's disease	3.67e-05	0.00914	CrCbGaD
Nortriptyline—Desipramine—CYP2D6—Alzheimer's disease	3.36e-05	0.00838	CrCbGaD
Nortriptyline—Imipramine—HTR2A—Alzheimer's disease	3.12e-05	0.00777	CrCbGaD
Nortriptyline—Amitriptyline—HTR2A—Alzheimer's disease	3.1e-05	0.00773	CrCbGaD
Nortriptyline—Imipramine—CYP2D6—Alzheimer's disease	2.85e-05	0.00711	CrCbGaD
Nortriptyline—Amitriptyline—CYP2D6—Alzheimer's disease	2.84e-05	0.00707	CrCbGaD
Nortriptyline—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.41e-06	3.61e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	2.4e-06	3.6e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TP53—Alzheimer's disease	2.4e-06	3.6e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	2.4e-06	3.59e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MAPK8—Alzheimer's disease	2.4e-06	3.59e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CALM1—Alzheimer's disease	2.39e-06	3.59e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	2.39e-06	3.59e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—AKT1—Alzheimer's disease	2.39e-06	3.58e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	2.39e-06	3.58e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—APOE—Alzheimer's disease	2.39e-06	3.58e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	2.39e-06	3.58e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	2.38e-06	3.57e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	2.37e-06	3.56e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—INS—Alzheimer's disease	2.37e-06	3.56e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	2.37e-06	3.56e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—INS—Alzheimer's disease	2.37e-06	3.56e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	2.37e-06	3.55e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—INS—Alzheimer's disease	2.37e-06	3.55e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—INS—Alzheimer's disease	2.37e-06	3.55e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	2.37e-06	3.55e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CAV1—Alzheimer's disease	2.36e-06	3.54e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	2.36e-06	3.54e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—INS—Alzheimer's disease	2.36e-06	3.54e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.36e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—INS—Alzheimer's disease	2.35e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.35e-06	3.52e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	2.35e-06	3.52e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	2.35e-06	3.52e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	2.34e-06	3.51e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	2.34e-06	3.5e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	2.34e-06	3.5e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	2.33e-06	3.5e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	2.33e-06	3.5e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—INS—Alzheimer's disease	2.33e-06	3.49e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	2.33e-06	3.49e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—LPL—Alzheimer's disease	2.33e-06	3.49e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	2.32e-06	3.48e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	2.32e-06	3.48e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	2.32e-06	3.47e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.3e-06	3.45e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.3e-06	3.45e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	2.3e-06	3.45e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	2.3e-06	3.44e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	2.3e-06	3.44e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	2.29e-06	3.44e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	2.29e-06	3.44e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	2.29e-06	3.43e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	2.29e-06	3.43e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	2.29e-06	3.43e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	2.28e-06	3.42e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	2.28e-06	3.41e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.26e-06	3.39e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PTGS2—Alzheimer's disease	2.26e-06	3.38e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	2.25e-06	3.38e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	2.25e-06	3.37e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	2.21e-06	3.32e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.19e-06	3.28e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.18e-06	3.26e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	2.16e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	2.15e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	2.15e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CALM1—Alzheimer's disease	2.15e-06	3.22e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—APOE—Alzheimer's disease	2.14e-06	3.21e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.14e-06	3.21e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CAV1—Alzheimer's disease	2.12e-06	3.18e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	2.12e-06	3.18e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.12e-06	3.17e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	2.12e-06	3.17e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	2.1e-06	3.14e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	2.08e-06	3.12e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—NOS3—Alzheimer's disease	2.08e-06	3.12e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PPARG—Alzheimer's disease	2.08e-06	3.12e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	2.08e-06	3.11e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—NOS3—Alzheimer's disease	2.08e-06	3.11e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	2.07e-06	3.1e-05	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.07e-06	3.1e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	2.06e-06	3.09e-05	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.05e-06	3.08e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	2.05e-06	3.07e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	2.04e-06	3.06e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—INS—Alzheimer's disease	2.04e-06	3.06e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	2.04e-06	3.06e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	2.04e-06	3.05e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	2.03e-06	3.05e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	2.03e-06	3.04e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—AKT1—Alzheimer's disease	2.03e-06	3.04e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	2.02e-06	3.03e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.02e-06	3.03e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.99e-06	2.99e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.99e-06	2.98e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.98e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.97e-06	2.95e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.97e-06	2.95e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.96e-06	2.94e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.96e-06	2.94e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.95e-06	2.93e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.95e-06	2.93e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	1.95e-06	2.92e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	1.94e-06	2.91e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	1.94e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.94e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	1.9e-06	2.85e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.9e-06	2.85e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.88e-06	2.82e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.88e-06	2.81e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.87e-06	2.8e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.87e-06	2.8e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.87e-06	2.8e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—INS—Alzheimer's disease	1.83e-06	2.74e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.83e-06	2.74e-05	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.81e-06	2.72e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.8e-06	2.69e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.79e-06	2.69e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.79e-06	2.68e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—NOS3—Alzheimer's disease	1.79e-06	2.68e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.79e-06	2.68e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.78e-06	2.68e-05	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.78e-06	2.67e-05	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.78e-06	2.67e-05	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.77e-06	2.66e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.77e-06	2.66e-05	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.77e-06	2.65e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.77e-06	2.65e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.76e-06	2.64e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.76e-06	2.64e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.76e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	1.75e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.75e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.75e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.75e-06	2.62e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.75e-06	2.62e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.74e-06	2.61e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.74e-06	2.6e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.74e-06	2.6e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.73e-06	2.59e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.73e-06	2.59e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.72e-06	2.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.72e-06	2.58e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.72e-06	2.57e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.7e-06	2.55e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.69e-06	2.53e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—INS—Alzheimer's disease	1.68e-06	2.52e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.68e-06	2.52e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.68e-06	2.51e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	1.67e-06	2.51e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.67e-06	2.5e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—INS—Alzheimer's disease	1.67e-06	2.5e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.65e-06	2.48e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.65e-06	2.48e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.65e-06	2.47e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.65e-06	2.47e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—Alzheimer's disease	1.64e-06	2.45e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.62e-06	2.43e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.62e-06	2.43e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.62e-06	2.43e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.62e-06	2.43e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.62e-06	2.42e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.62e-06	2.42e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.61e-06	2.42e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.61e-06	2.41e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.61e-06	2.41e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.6e-06	2.41e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	1.6e-06	2.4e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.6e-06	2.39e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.59e-06	2.39e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.59e-06	2.38e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.59e-06	2.38e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.59e-06	2.38e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.59e-06	2.38e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.54e-06	2.3e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	1.53e-06	2.29e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.52e-06	2.28e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.52e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	1.51e-06	2.26e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.5e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.5e-06	2.24e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.5e-06	2.24e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.49e-06	2.24e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.49e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.48e-06	2.21e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.47e-06	2.21e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.47e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.47e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	1.47e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.46e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.45e-06	2.18e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—INS—Alzheimer's disease	1.43e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	1.41e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.4e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.38e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	1.38e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.38e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.37e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.37e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.36e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	1.35e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.35e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.35e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.35e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.34e-06	2.01e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.31e-06	1.97e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.31e-06	1.96e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.29e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.29e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—Alzheimer's disease	1.28e-06	1.92e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.28e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	1.27e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.25e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.25e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.2e-06	1.8e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.19e-06	1.79e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.15e-06	1.73e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.14e-06	1.71e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	1.14e-06	1.71e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—Alzheimer's disease	1.13e-06	1.7e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.13e-06	1.7e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.13e-06	1.7e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	1.13e-06	1.69e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	1.12e-06	1.68e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.12e-06	1.68e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.11e-06	1.67e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.11e-06	1.66e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.11e-06	1.66e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.1e-06	1.65e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—INS—Alzheimer's disease	1.1e-06	1.65e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	1.05e-06	1.58e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.05e-06	1.58e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.04e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.04e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1.03e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	1.03e-06	1.54e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	1.53e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	9.73e-07	1.46e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NOS3—Alzheimer's disease	9.65e-07	1.45e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	9.57e-07	1.43e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—Alzheimer's disease	9.56e-07	1.43e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	9.55e-07	1.43e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—Alzheimer's disease	9.54e-07	1.43e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	9.52e-07	1.43e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	9.49e-07	1.42e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	9.4e-07	1.41e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	9.37e-07	1.4e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	8.83e-07	1.32e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—Alzheimer's disease	8.22e-07	1.23e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—Alzheimer's disease	7.38e-07	1.11e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—Alzheimer's disease	6.79e-07	1.02e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—Alzheimer's disease	6.73e-07	1.01e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—Alzheimer's disease	5.75e-07	8.62e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—Alzheimer's disease	4.44e-07	6.65e-06	CbGpPWpGaD
